Intrinsic Value of S&P & Nasdaq Contact Us

ARCA biopharma, Inc. ABIO NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
49/100
2/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ABIO

ARCA biopharma, Inc. (ABIO) has a market capitalization of $34.82M and trades at $28.80. The 52-week range is 2.2469-53.88.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.2, Earnings Per Share (EPS) of $-154.03.

The stock has a beta of 0.90, a last dividend of $3.1800, operates in the Healthcare sector.

Trading Data
Current Price$28.80
52-Week Range2.2469-53.88
Volume290.85K
Avg Volume (30D)13.86K
Market Cap$34.82M
Beta (1Y)0.90
Last Dividend$3.1800
Company
IPO Date1997-08-08
Employees3
CEOThomas A. Keuer
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS00211Y5069
CUSIP00211Y506
Income (Latest Year)
EBITDA$-122.05M
Operating Income$-122.05M
Net Income$-105.43M
EPS$-154.03
EPS Diluted$-154.03
Shares Outstanding$45.61K
Balance Sheet (Latest Year)
Total Assets$488.62M
Current Assets$343.86M
Cash & ST Investments$337.04M
Total Liabilities$16.69M
Total Debt$1.93M
Net Debt$-45M
Total Equity$471.93M
Debt / Equity0.00
Valuation Ratios
P/E Ratio-0.2
P/B Ratio0.07
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message